Three Republican-led states are launching a new legal challenge aimed at restricting access to abortion pills, opening another major front in the continuing U.S. healthcare and reproductive-rights battle.

Louisiana, Alabama and Arkansas have filed lawsuits arguing that abortion medications distributed through telehealth and mail should be treated as a public nuisance. The states are targeting providers and organizations in states such as New York, California and Massachusetts that have adopted protections for abortion providers.

The lawsuits represent an unusual legal strategy and could test the boundaries between state abortion restrictions, federal drug regulation and so-called shield laws. The cases also come as telehealth has become an increasingly important way for patients in restrictive states to obtain abortion medication.

According to Reuters, about 91,000 abortions in states with abortion bans were facilitated through telehealth in 2025, up from approximately 74,000 in 2024. The legal challenges could therefore have significant implications for abortion access and healthcare providers operating across state lines.

The cases add another layer of uncertainty to the U.S. healthcare system following the Supreme Court's 2022 decision overturning Roe v. Wade.